SEC Form 4 · accession 0001179110-17-010998
USANA HEALTH SCIENCES INC · USNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gull Global Ltd
10% Owner
Period of report
Aug 1, 2017
Accepted (ET)
Aug 2, 2017 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 1, 2017 | S | 25,467 | $56.5183 | D | 12,352,753 | D | |
| Common StockF1,F2,F4 | Aug 2, 2017 | S | 14,533 | $56.7092 | D | 12,338,220 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017.
- F3Weighted average price. Price range in multiple transactions was $56.10 to $57.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
- F4Weighted average price. Price range in multiple transactions was $56.15 to $57.40, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.